Assessment of the three-test genetic toxicology battery for groundwater metabolites
Mutagenesis · 2024
DOI: 10.1093/mutage/gead037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mutagenesis, 2024. Verfasst von Paul Fowler und 9 weiteren Autor:innen. Beteiligte Einrichtung: FStox Consulting Ltd, Raunds, United Kingdom. Hauptthemen laut MEDLINE: Hypoxanthine Phosphoribosyltransferase, Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CropLife Europe Organized and Funded.
Abstract (Originalsprache)
The two-test in vitro battery for genotoxicity testing (Ames and micronucleus) has in the majority of cases replaced the three-test battery (as two-test plus mammalian cell gene mutation assay) for the routine testing of chemicals, pharmaceuticals, cosmetics, and agrochemical metabolites originating from food and feed as well as from water treatment. The guidance for testing agrochemical groundwater metabolites, however, still relies on the three-test battery. Data collated in this study from 18 plant protection and related materials highlights the disparity between the often negative Ames and in vitro chromosome aberration data and frequently positive in vitro mammalian cell gene mutation assays. Sixteen of the 18 collated materials with complete datasets were Ames negative, and overall had negative outcomes in in vitro chromosome damage tests (weight of evidence from multiple tests). Mammalian cell gene mutation assays (HPRT and/or mouse lymphoma assay (MLA)) were positive in at least one test for every material with this data. Where both MLA and HPRT tests were performed on the same material, the HPRT seemed to give fewer positive responses. In vivo follow-up tests included combinations of comet assays, unscheduled DNA synthesis, and transgenic rodent gene mutation assays, all gave negative outcomes. The inclusion of mammalian cell gene mutation assays in a three-test battery for groundwater metabolites is therefore not justified and leads to unnecessary in vivo follow-up testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- FStox Consulting Ltd, Raunds, United Kingdom.
- Sipcam Oxon S.p.A., Italy.
- Corteva, Abingdon, United Kingdom.
- Syngenta Ltd., Berkshire, UK.
- Exigent Sciences LLC, Arizona, United States.
- Bayer AG, Monheim, Germany.
ORCID-Profile: Paul Fowler, Carol Beevers
Förderung
- CropLife Europe Organized and Funded
Zitieren
APA
Fowler, P., Bearzatto, A., Beevers, C., Booth, E. D., Donner, E. M., Gan, L., Hartmann, K., Meurer, K., Schutte, M. E., & Settivari, R. S. (2024). Assessment of the three-test genetic toxicology battery for groundwater metabolites. Mutagenesis. https://doi.org/10.1093/mutage/gead037
Vancouver
Fowler P, Bearzatto A, Beevers C, Booth ED, Donner EM, Gan L, et al. Assessment of the three-test genetic toxicology battery for groundwater metabolites. Mutagenesis. 2024. doi:10.1093/mutage/gead037
BibTeX
@article{Fowler2024,
author = {Fowler, Paul and Bearzatto, Alessandra and Beevers, Carol and Booth, Ewan D and Donner, E Maria and Gan, Lin and Hartmann, Kerstin and Meurer, Krista and Schutte, Maaike E and Settivari, Raja S},
title = {Assessment of the three-test genetic toxicology battery for groundwater metabolites},
journal = {Mutagenesis},
year = {2024},
doi = {10.1093/mutage/gead037}
}
EUVIMED